Project Censored
  • Support Our Work
  • Store
  • About
    • Mission
    • Who We Are
    • Media Freedom Foundation
    • Classroom
    • History of Project Censored
    • Our Work
    • Project Censored Summer Internships
    • Endorsements
    • The Newest Project Censored Movie
    • Events
    • Privacy Policy
    • Cookie Policy
  • Radio Show
    • The Project Censored Show

      Global Civil War: Capitalism Post Pandemic

      May 16, 2022

      The Project Censored Show

      PayPal, US/NATO, Biden’s Disinformation Governance Board, Roe vs….

      May 9, 2022

      The Project Censored Show

      Book Banning on the Rise in the US

      May 6, 2022

      The Project Censored Show

      Special Guests Valena Beety, Geoff Davidian, and Dr….

      April 25, 2022

      The Project Censored Show

      Special Guests Leonardo Flores and Jacquie Luqman Discuss…

      April 19, 2022

      The Project Censored Show

      Big Tech Censorship With Special Guests Chris Hedges…

      April 12, 2022

      The Project Censored Show

      Code Pink’s Panel on Media Censorship of Voices…

      April 6, 2022

  • Notebook
    • All Newsletters
      Censored Notebook

      THE PROJECT CENSORED NEWSLETTER April 2022

      April 16, 2022

      Censored Notebook

      THE PROJECT CENSORED NEWSLETTER – March 2022

      March 25, 2022

      Censored Notebook

      THE PROJECT CENSORED NEWSLETTER – February 2022

      February 21, 2022

      Censored Notebook

      Arrests Aim to Silence Kashmiri Journalists and Human…

      February 5, 2022

      Censored Notebook

      Cal State Poly, Pomona Professor Accused of Anti-Semitism

      January 31, 2022

      Censored Notebook

      The Project Censored Newsletter—January 2022

      January 26, 2022

      Newsletters

      THE PROJECT CENSORED NEWSLETTER April 2022

      April 16, 2022

      Newsletters

      THE PROJECT CENSORED NEWSLETTER – March 2022

      March 25, 2022

      Newsletters

      THE PROJECT CENSORED NEWSLETTER – February 2022

      February 21, 2022

      Newsletters

      The Project Censored Newsletter—January 2022

      January 26, 2022

      Newsletters

      The Project Censored Newsletter—December 2021

      December 11, 2021

      Newsletters

      The Project Censored Newsletter—November 2021

      November 6, 2021

  • News
    • Validated Independent News

      State of the Billionaire Press: Concerns over Media…

      April 21, 2022

      Validated Independent News

      McDonald’s Dodged Millions in Taxes with an IOU…

      April 21, 2022

      Validated Independent News

      Donor-Advised Funds Take Advantage of Tax Loopholes

      April 21, 2022

      Validated Independent News

      Book Donation Bans in US Prisons Restrict Prisoners’…

      April 20, 2022

      Validated Independent News

      St. Jude Hoards Billions While Running Misleading Advertising…

      April 20, 2022

      Validated Independent News

      US Transportation System “Fuels” Inequality

      April 20, 2022

      Validated Independent News

      Former Neo-Nazi Leader Now Holds DOJ Domestic Counterterrorism…

      April 20, 2022

Project Censored

  • Support Our Work
  • Store
  • About
    • Mission
    • Who We Are
    • Media Freedom Foundation
    • Classroom
    • History of Project Censored
    • Our Work
    • Project Censored Summer Internships
    • Endorsements
    • The Newest Project Censored Movie
    • Events
    • Privacy Policy
    • Cookie Policy
  • Radio Show
    • The Project Censored Show

      Global Civil War: Capitalism Post Pandemic

      May 16, 2022

      The Project Censored Show

      PayPal, US/NATO, Biden’s Disinformation Governance Board, Roe vs….

      May 9, 2022

      The Project Censored Show

      Book Banning on the Rise in the US

      May 6, 2022

      The Project Censored Show

      Special Guests Valena Beety, Geoff Davidian, and Dr….

      April 25, 2022

      The Project Censored Show

      Special Guests Leonardo Flores and Jacquie Luqman Discuss…

      April 19, 2022

      The Project Censored Show

      Big Tech Censorship With Special Guests Chris Hedges…

      April 12, 2022

      The Project Censored Show

      Code Pink’s Panel on Media Censorship of Voices…

      April 6, 2022

  • Notebook
    • All Newsletters
      Censored Notebook

      THE PROJECT CENSORED NEWSLETTER April 2022

      April 16, 2022

      Censored Notebook

      THE PROJECT CENSORED NEWSLETTER – March 2022

      March 25, 2022

      Censored Notebook

      THE PROJECT CENSORED NEWSLETTER – February 2022

      February 21, 2022

      Censored Notebook

      Arrests Aim to Silence Kashmiri Journalists and Human…

      February 5, 2022

      Censored Notebook

      Cal State Poly, Pomona Professor Accused of Anti-Semitism

      January 31, 2022

      Censored Notebook

      The Project Censored Newsletter—January 2022

      January 26, 2022

      Newsletters

      THE PROJECT CENSORED NEWSLETTER April 2022

      April 16, 2022

      Newsletters

      THE PROJECT CENSORED NEWSLETTER – March 2022

      March 25, 2022

      Newsletters

      THE PROJECT CENSORED NEWSLETTER – February 2022

      February 21, 2022

      Newsletters

      The Project Censored Newsletter—January 2022

      January 26, 2022

      Newsletters

      The Project Censored Newsletter—December 2021

      December 11, 2021

      Newsletters

      The Project Censored Newsletter—November 2021

      November 6, 2021

  • News
    • Validated Independent News

      State of the Billionaire Press: Concerns over Media…

      April 21, 2022

      Validated Independent News

      McDonald’s Dodged Millions in Taxes with an IOU…

      April 21, 2022

      Validated Independent News

      Donor-Advised Funds Take Advantage of Tax Loopholes

      April 21, 2022

      Validated Independent News

      Book Donation Bans in US Prisons Restrict Prisoners’…

      April 20, 2022

      Validated Independent News

      St. Jude Hoards Billions While Running Misleading Advertising…

      April 20, 2022

      Validated Independent News

      US Transportation System “Fuels” Inequality

      April 20, 2022

      Validated Independent News

      Former Neo-Nazi Leader Now Holds DOJ Domestic Counterterrorism…

      April 20, 2022

#14. The Case for a Public Pharmaceutical System

by Project Censored December 1, 2020
December 1, 2020

A September 2019 report by the Democracy Collaborative outlined a model for a democratic public pharmaceutical system, as Fran Quigley reported for Common Dreams. According to the report, the existing pharmaceutical industry, which depends on government-granted patent monopolies, “operates on an extractive model that contributes to inequality and increasingly produces drug shortages, inefficiency, lagging innovation, misinformation and misuse of medications, and most famously, the world’s highest drug prices.” Instead of piecemeal reform of existing patent and anti-trust laws or government provisions of health insurance—any of which could later be repealed—public ownership of pharmaceutical development, production, and distribution offers a systemic approach to fixing Big Pharma’s most fundamental flaws, according to “Medicine for All,” the Democracy Collaborative’s report.

The Democracy Collaborative model includes plans for a national public pharmaceutical research and development institute for developing new drugs to meet public health needs; state, local, and regional public pharmaceutical manufacturers; regionally owned and operated public wholesale distributors; and engaging the US Postal Service as a partner for pharmaceutical distribution.

As Fran Quigley wrote for Common Dreams, the foundation for these changes is “already in place” because public funding “has long been the bedrock of pharmaceutical research and development.” From 2010 to 2016, “every single one” of 210 newly approved drugs traced their origins back to taxpayer-sponsored research, Quigley reported, based on a study published by PNAS in March 2018.

In almost every case, Dean Baker wrote in Truthout in July 2019, drugs are “cheap to manufacture,” but government-granted patent monopolies make them expensive for consumers. Both Baker’s Truthout article and a report for MintPress News by Alan MacLeod addressed the explanations for high drug prices typically made by defenders of the current system. In the existing model, “it is expensive to develop new drugs” and patent monopolies provide companies incentives to take the risks necessary to do so, Baker related. But, he wrote, there is “nothing natural” about a patent-based system for financing drug research and development. Instead, patent monopolies give drug companies “an enormous incentive to push their drugs as widely as possible.” The opioid crisis, he noted, is an extreme case of how drug companies exaggerate their drugs’ benefits and conceal their negative side effects. But, Baker wrote, “Purdue Pharma would not have been pushing OxyContin so vigorously if it were selling at generic prices.” [Note: On Big Pharma’s “documented history” of dangerous and illegal misbranding, and its multi-billion dollar expenditures to influence doctors’ prescribing decisions, also see Brown, “Medicine for All,” 19.]

The current system also leads to lost government revenues—which could otherwise be directed to healthcare and public services—through tax evasion: As revealed by the Panama Papers, in 2015 ten of the thirty US companies holding the most money offshore were pharmaceutical companies, which together held more than $506 billion in offshore accounts not subject to US taxes.

Publicly-owned pharmaceuticals, freed from the financial demand to appease profit-hungry shareholders, would be able to focus on public health priorities, working hand-in-hand with public health departments, as they do in other countries, to assure an adequate supply of medications, priced to be accessible to the broadest array of Americans. As Fran Quigley reported for Common Dreams, Sweden, Brazil, Cuba, Thailand, and China (among others) “embrace public ownership in key components of their medicines systems,” offering working examples of what could be achieved in the United States. 

Although the United States has a reputation for being “politically and culturally suspicious of public systems replacing markets,” two-thirds of Americans “support making prescription drugs public goods paid for by the federal government,” and eight in ten support “breaking patent monopolies to reduce drug prices,” Quigley reported. [Note: A September 2019 New Republic article noted that the public is “mad as hell about drug prices” and cited the results of March 2019 Kaiser Family Foundation poll, which found that 79 percent of respondents believed drug prices were unreasonable, 80 percent attributed that partly to drug company profits, and 89 percent—including 85 percent of Republicans—favored making it easier for generics to come to market. See Libby Watson, “Democrats’ Drug Price Bill May be Dead on Arrival,” New Republic, September 20, 2019, https://newrepublic.com/article/155140/democrats-drug-price-bill-may-dead-arrival.]

In February 2020, Public Citizen published a report showing how the COVID-19 pandemic has exposed the limits of Big Pharma’s monopoly model. Public Citizen’s “Blind Spot” report determined that, since the 2002 severe acute respiratory syndrome (SARS) outbreak, the National Institutes of Health have invested “nearly $700 million [in taxpayer funding] on coronavirus R&D.” Indeed, all six of the coronavirus clinical trials active in 2019 “depended crucially on public funding.” Although “more sustained interest in coronaviruses could have provided greater scientific understanding, and a stronger toolkit to inform the latest response,” Zain Rizvi wrote, the private sector has lagged behind in developing treatments for infectious diseases because they are “less lucrative” than medicines for chronic conditions and rare diseases. As Rizvi’s Public Citizen report concluded, the COVID-19 crisis highlights the “urgent need” for an alternative to the existing “monopoly-based model,” which prioritizes short-term corporate profits over public health. 

While consistently covering partisan political disputes over prescription drug prices, corporate news media have been relatively mute in reporting on proposals to develop a public pharmaceutical alternative to Big Pharma. In particular, as of May 2020 no corporate news outlets appear to have covered the Democracy Collaborative’s “Medicine for All” report.


Fran Quigley, “Removing the Profit from Our Pills: The Case for a Public Pharma System,” Common Dreams, September 18, 2019, https://www.commondreams.org/views/2019/09/18/removing-profit-our-pills-case-public-pharma-system.

Dean Baker, “Replace Patent Monopolies with Direct Public Funding for Drug Research,” Truthout, July 1, 2019, https://truthout.org/articles/replace-patent-monopolies-with-direct-public-funding-for-drug-research/.

Alan MacLeod, “Economist Dean Baker: Systemic Change Needed to Fight Big Pharma Price Gouging,” MintPress News, December 12, 2019, https://www.mintpressnews.com/dean-baker-gilead-hiv-pofits-drug-prices/263412/.

Zain Rizvi, “Blind Spot: How the COVID-19 Outbreak Shows the Limits of Pharma’s Monopoly Model,” Public Citizen, February 19, 2020, https://www.citizen.org/article/blind-spot/.

Student Researchers: Jennifer Pope (San Francisco State University) and Amber Yang (Sonoma State University)

Faculty Evaluator: Kenn Burrows (San Francisco State University)

Review Article with Credder
1
FacebookTwitter
previous post
#13. Lessons from Colorado’s Voting System
next post
#15. Indigenous Trauma and Suicide an Enduring Legacy of Colonialism

You may also like

A Note on Research and Evaluation of Censored...

December 1, 2020

#25. Studies Document Links between Education, Incarceration, and...

December 1, 2020

#24. Silenced in Savannah: Journalist Abby Martin Challenges...

December 1, 2020

#23. “Global Gag Rule” Continues to Compromise Women’s...

December 1, 2020

#22. An Emergency Wealth Tax to Confront Coronavirus...

December 1, 2020

#21. The Scourge of Human Trafficking in Yemen

December 1, 2020

#20. A Comprehensive Framework for Transforming the Criminal-Legal...

December 1, 2020

#19. Antibiotic Abuse: Pharmaceutical Profiteering Accelerates Superbugs

December 1, 2020

#18. Trump Labor Board Assaults Workers’ Rights

December 1, 2020

#17. International Plasma Market Profits from US and...

December 1, 2020

Become a Monthly Supporter For Only $10 and Get the Newest Book for Free!

Become a Monthly Supporter Here!Project Censored 2022 Top Censored Stories Book

We depend on member support to continue our research on news censorship, media literacy education, maintain our websites, and to write our annual book!

 

 

 

 

Help Support the New Censored Press!

Censored PRess

Support the Launch of the Censored Press

6% funded
$
Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.

Donation Total: $25.00

Donate With Cryptocurrency

Donate to Project Censored

The Latest Project Censored Show

Global Civil War: Capitalism Post Pandemic

https://www.projectcensored.org/podcast-player/25765/global-civil-war-capitalism-post-pandemic.mp3

More Information

  • What is Modern Censorship?
  • Contact Us
  • For Teachers
  • Workshop For Educators

Partner Websites

  • ACME
  • EmpireFiles
  • GCMLP
  • KBBF
  • KPFA
  • Mass Media Literacy
  • Media Roots
  • The Memory Hole
  • MintPress News
  • National Coalition Against Censorship
  • News Enlightenment Initiative (Project Censored Germany)
  • Open the Gov
  • Random Lengths News
  • The RealNews
  • Society of Professional Journalists
  • WPOV – From a Woman’s Point of View

More

  • The Top 25 Archive
  • Nominate a Story
  • Project Censored in the Classroom
  • Independent News Sources
  • Fair Use Statement
  • Facebook
  • Twitter
  • Instagram
  • Youtube

All Rights Reserved by Media Freedom Foundation. No part of the content on this website may be republished without written consent by Media Freedom Foundation


Back To Top
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT